1.
Emerg Infect Dis
; 27(10): 2662-2665, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34399086
RESUMO
We used the BinaxNOW COVID-19 Ag Card to screen 1,540 asymptomatic college students for severe acute respiratory syndrome coronavirus 2 in a low-prevalence setting. Compared with reverse transcription PCR, BinaxNOW showed 20% overall sensitivity; among participants with culturable virus, sensitivity was 60%. BinaxNOW provides point-of-care screening but misses many infections.
